Back
Denali Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
59
DNLI
Denali Therapeutics, Inc.
Last Price:
$17.35
Seasonality Move:
-10.54%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19 | Sell |
| 20-day SMA: | 18.4 | Sell |
| 50-day SMA: | 16.85 | Buy |
| 200-day SMA: | 15.02 | Buy |
| 8-day EMA: | 18.93 | Sell |
| 20-day EMA: | 18.35 | Sell |
| 50-day EMA: | 17.13 | Buy |
| 200-day EMA: | 16.61 | Buy |
Denali Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 47.3 | Sell |
| Chaikin Money Flow: | -5770738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.25 - 19.39) | Sell |
| Bollinger Bands (100): | (13.82 - 17.36) | Buy |
Denali Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics, Inc. Stock
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 17.57 while DNLI 8-day simple moving average is 19.00, which is a Sell signal.
-
The stock price of DNLI is 17.57 while Denali Therapeutics, Inc. 20-day SMA is 18.40, which makes it a Sell.
-
Denali Therapeutics, Inc. 50-day simple moving average is 16.85 while DNLI share price is 17.57, making it a Buy technically.
-
DNLI stock price is 17.57 and Denali Therapeutics, Inc. 200-day simple moving average is 15.02, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
59
Denali Therapeutics, Inc. (DNLI)
is a Buy
Is Denali Therapeutics, Inc. a Buy or a Sell?
-
Denali Therapeutics, Inc. stock is rated a BuyThe current Denali Therapeutics, Inc. [DNLI] share price is $17.57. The Score for DNLI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics, Inc. Stock Info
Market Cap:
2.6B
Price in USD:
17.57
Share Volume:
6.1M
Denali Therapeutics, Inc. 52-Week Range
52-Week High:
24.69
52-Week Low:
10.57
Buy
59
Denali Therapeutics, Inc. (DNLI)
is a Buy
Denali Therapeutics, Inc. Share Price Forecast
-
What is the Denali Therapeutics, Inc. stock price today?The Denali Therapeutics, Inc. stock price is 17.57 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics, Inc. is not overvalued.
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 17.57 while DNLI 8-day exponential moving average is 18.93, which is a Sell signal.
-
The stock price of DNLI is 17.57 while Denali Therapeutics, Inc. 20-day EMA is 18.35, which makes it a Sell.
-
Denali Therapeutics, Inc. 50-day exponential moving average is 17.13 while DNLI share price is 17.57, making it a Buy technically.
-
DNLI stock price is 17.57 and Denali Therapeutics, Inc. 200-day simple moving average is 16.61, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics, Inc.
Is Denali Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.04 per share.
Technical Analysis of Denali Therapeutics, Inc.
Should I short Denali Therapeutics, Inc. stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is 0.74, suggesting Denali Therapeutics, Inc. is a Buy
-
Denali Therapeutics, Inc. Relative Strength Index (RSI) is 47.3, which suggest Denali Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Denali Therapeutics, Inc. is (16.25 - 19.39), which suggest Denali Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Denali Therapeutics, Inc. is (13.82 - 17.36), which suggest Denali Therapeutics, Inc. is a Buy
* Denali Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.